Reaction
Intercepted Product Dispensing Error reporting signals
As of the last recalculation, Intercepted Product Dispensing Error appears in 1,601 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TIRZEPATIDE (PRR 69.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tirzepatide | 563 | 69.3 | 69.6 |
| Galcanezumab-Gnlm | 26 | 10.9 | 10.9 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 22 | 7.0 | 7.0 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 8 | 6.3 | 6.3 |
| Remdesivir | 5 | 4.9 | 4.9 |
| Nirmatrelvir And Ritonavir | 19 | 4.6 | 4.6 |
| Leuprolide Acetate | 26 | 4.4 | 4.4 |
| Dulaglutide | 28 | 4.2 | 4.2 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 5 | 3.6 | 3.6 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 3.4 | 3.4 |
| Ixekizumab | 7 | 2.5 | 2.5 |